跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
antibodies (age related macular degeneration)
首页
药物
antibodies (age related macular degeneration)
antibodies (age related macular degeneration)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
METHODS OF TREATING OPHTHALMIC DISEASES
申请人: RINAT NEUROSCIENCE CORP
优先权: 2007
CN
US
2 件公开
NOVEL COMPLEMENT SYSTEM INHIBITING ANTIBODIES
申请人: 4D MOLECULAR THERAPEUTICS INC
优先权: 2023
CN
EP
WO
3 件公开
Rod-derived cone viability factor (RDCVF) and a method of enhancing cone cell survival by RDCVF
申请人: NOVARTIS AG
优先权: 2002
US
12 件公开
TREATMENT OF OPHTHALMOLOGIC DISEASES
申请人: HOFFMANN LA ROCHE
优先权: 2018
EP
US
2 件公开
Methods and compositions for diagnosing Alzheimer's disease and age-related macular degeneration
申请人: UNIV OKLAHOMA
优先权: 2013
US
METHODS AND MATERIALS FOR TREATING OCULAR NEOVASCULAR DISEASES
申请人: MASSACHUSETTS EYE & EAR INFIRMARY
优先权: 2024
WO
Anti-apelin antibodies and uses thereof
申请人: PHANES THERAPEUTICS INC
优先权: 2018
US
Complement factor D antagonist antibodies and conjugates thereof
申请人: KODIAK SCIENCES INC
优先权: 2018
US
2 件公开
药物
反馈